Tower Research Capital (TRC)’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,786
| Closed | -$2K | – | 6829 |
|
|
2022
Q3 | $2K | Sell |
8,786
-3,797
| -30% | -$1.66K | ﹤0.01% | 5709 |
|
|
2022
Q2 | $10K | Buy |
+12,583
| New | +$11.2K | ﹤0.01% | 4522 |
|
|
2022
Q1 | – | Sell |
-16,793
| Closed | -$32K | – | 7010 |
|
|
2021
Q4 | $32K | Buy |
16,793
+14,663
| +688% | +$35.1K | ﹤0.01% | 3181 |
|
|
2021
Q3 | $6K | Sell |
2,130
-4,397
| -67% | -$15.7K | ﹤0.01% | 4803 |
|
|
2021
Q2 | $26K | Sell |
6,527
-13,916
| -68% | -$57.7K | ﹤0.01% | 3662 |
|
|
2021
Q1 | $104K | Buy |
20,443
+10,542
| +106% | +$54.7K | ﹤0.01% | 2560 |
|
|
2020
Q4 | $40K | Sell |
9,901
-12,893
| -57% | -$63.3K | ﹤0.01% | 3339 |
|
|
2020
Q3 | $111K | Buy |
22,794
+21,303
| +1,429% | +$116K | ﹤0.01% | 3079 |
|
|
2020
Q2 | $8K | Sell |
1,491
-2,565
| -63% | -$11.7K | ﹤0.01% | 4131 |
|
|
2020
Q1 | $13K | Buy |
4,056
+3,106
| +327% | +$16.4K | ﹤0.01% | 1920 |
|
|
2019
Q4 | $4K | Buy |
+950
| New | +$3K | ﹤0.01% | 2843 |
|
|
2019
Q3 | – | Sell |
-253
| Closed | -$1K | – | 4680 |
|
|
2019
Q2 | $1K | Sell |
253
-7,647
| -97% | -$31.3K | ﹤0.01% | 3531 |
|
|
2019
Q1 | $33K | Buy |
7,900
+314
| +4% | +$1.1K | ﹤0.01% | 1986 |
|
|
2018
Q4 | $19K | Buy |
7,586
+6,523
| +614% | +$38.2K | ﹤0.01% | 1999 |
|
|
2018
Q3 | $8K | Sell |
1,063
-18,897
| -95% | -$82.7K | ﹤0.01% | 2920 |
|
|
2018
Q2 | $73K | Buy |
19,960
+18,406
| +1,184% | +$85.2K | ﹤0.01% | 1633 |
|
|
2018
Q1 | $5K | Buy |
+1,554
| New | +$6.53K | ﹤0.01% | 2739 |
|
|
2017
Q4 | – | Sell |
-6,656
| Closed | -$26K | – | 4206 |
|
|
2017
Q3 | $26K | Buy |
6,656
+2,438
| +58% | +$11.2K | ﹤0.01% | 2564 |
|
|
2017
Q2 | $22K | Buy |
+4,218
| New | +$23.7K | ﹤0.01% | 1174 |
|
|
2017
Q1 | – | Sell |
-360
| Closed | -$4K | – | 4157 |
|
|
2016
Q4 | $4K | Buy |
+360
| New | +$3.24K | ﹤0.01% | 3185 |
|
|
2016
Q3 | – | Sell |
-863
| Closed | -$12K | – | 4715 |
|
|
2016
Q2 | $12K | Sell |
863
-2,226
| -72% | -$34.7K | ﹤0.01% | 2683 |
|
|
2016
Q1 | $43K | Buy |
+3,089
| New | +$45.3K | 0.01% | 866 |
|
|
2015
Q3 | – | Sell |
-314
| Closed | -$5K | – | 5014 |
|
|
2015
Q2 | $5K | Sell |
314
-1,559
| -83% | -$29.9K | ﹤0.01% | 3284 |
|
|
2015
Q1 | $38K | Buy |
1,873
+282
| +18% | +$6.3K | ﹤0.01% | 1709 |
|
|
2014
Q4 | $33K | Buy |
1,591
+1,491
| +1,491% | +$30.4K | ﹤0.01% | 1284 |
|
|
2014
Q3 | $2K | Sell |
100
-590
| -86% | -$10.7K | ﹤0.01% | 3909 |
|
|
2014
Q2 | $16K | Buy |
+690
| New | +$12.2K | ﹤0.01% | 2004 |
|
Tower Research Capital (TRC)'s AGTC Position: Q4 2022 in Review
Tower Research Capital (TRC) sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 8,786 shares — an estimated $2K sold.
Tower Research Capital (TRC) first reported a position in AGTC in Q2 2014 and held it in 27 quarters. The position peaked at $111K in Q3 2020. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Tower Research Capital (TRC) reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 8,786 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $2K.
- Tower Research Capital (TRC) first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 27 quarters.
- Tower Research Capital (TRC)'s Applied Genetic Technologies Corporation position peaked at $111K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.